Birchview Capital, LP - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 188 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.4%.

Quarter-by-quarter ownership
Birchview Capital, LP ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$684,720
-37.4%
18,000
+50.0%
0.58%
-28.8%
Q2 2023$1,093,200
+137930.3%
12,0000.0%0.82%
+32.1%
Q1 2023$792
+27.5%
12,0000.0%0.62%
+41.2%
Q4 2022$621
-99.9%
12,0000.0%0.44%
-23.9%
Q3 2022$820,000
+51.0%
12,0000.0%0.58%
+46.1%
Q2 2022$543,000
-11.0%
12,0000.0%0.40%
-10.0%
Q1 2022$610,000
+7.6%
12,0000.0%0.44%
+19.9%
Q4 2021$567,000
+43.2%
12,0000.0%0.37%
+36.1%
Q3 2021$396,000
-21.7%
12,000
+50.0%
0.27%
-11.2%
Q2 2021$506,000
+47.5%
8,0000.0%0.30%
+48.5%
Q1 2021$343,000
-25.1%
8,0000.0%0.20%
-22.7%
Q4 2020$458,000
-5.0%
8,000
-50.0%
0.26%
+64.0%
Q3 2020$482,000
+84.7%
16,000
+100.0%
0.16%
+1.9%
Q2 2020$261,000
+22.0%
8,0000.0%0.16%
-16.8%
Q1 2020$214,000
-12.7%
8,0000.0%0.19%
+6.7%
Q4 2019$245,000
+20.7%
8,0000.0%0.18%
+44.7%
Q2 2019$203,0008,0000.12%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,130,000$119,065,20018.29%
EcoR1 Capital, LLC 10,899,859$414,630,63613.99%
Ally Bridge Group (NY) LLC 181,805$6,915,8628.12%
Avoro Capital Advisors LLC 11,111,111$422,666,6626.59%
ACUTA CAPITAL PARTNERS, LLC 244,484$9,300,1716.23%
Iron Triangle Partners LP 880,000$33,475,2004.89%
Cormorant Asset Management, LP 2,000,000$76,080,0004.44%
Octagon Capital Advisors LP 675,000$25,677,0003.94%
Logos Global Management LP 750,000$28,530,0003.81%
Boxer Capital, LLC 1,726,000$65,657,0403.50%
View complete list of APELLIS PHARMACEUTICALS INC shareholders